← Back to Clinical Trials
Recruiting NCT06669715

NCT06669715 Evaluation of Physical Fitness and Hemodynamics Across a Diverse Population

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06669715
Status Recruiting
Phase
Sponsor University of Ljubljana
Condition Prehypertension (Elevated Blood Pressure) or Hypertension
Study Type OBSERVATIONAL
Enrollment 30 participants
Start Date 2024-11-04
Primary Completion 2027-05-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 30 participants in total. It began in 2024-11-04 with a primary completion date of 2027-05-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

In this study, investigators will use the IFT 30-15 test, a six-minute walking test, and a treadmill test to assess the participants' cardiorespiratory fitness. For the treadmill cardiopulmonary exercise test (CPET), we will measure indirect gas exchange using a CPET device (K5). Maximum heart rate (HRmax) will be measured with a Polar heart rate monitor (model H10). The six-minute walking test will follow standardized procedures, and the treadmill test will follow a protocol of gradually increasing speed each minute. The study will involve two groups of participants: healthy individuals and pre-hypertensive individuals. While the IFT 30-15 test has been validated on a diverse range of athletes and physically active individuals, it has not yet been validated in individuals with similar characteristics to our participants (BMI \> 30 and limited cardiovascular function). Additionally, a variety of hemodynamic measures and other physical function measures such as sit-to-stand and push-ups will be assessed for all participants.

Eligibility Criteria

Inclusion Criteria: * Adults (18 + years of age) without restriction on sex, health status or physical fitness. Exclusion Criteria: * Inability to walk without assistance * Presence of acute injuries and/or illnesses that limit maximal exertion during physical fitness testing * Lower extremity injury or surgery within the past 2 years (if not fully rehabilitated)

Contact & Investigator

Central Contact

Armin H Researcher, PhD

✉ armin.paravlic@fsp.uni-lj.si

📞 +386015207840

Principal Investigator

Armin Paravlic, PhD

PRINCIPAL INVESTIGATOR

Faculty of Sport, University of Ljubljana

Frequently Asked Questions

Who can join the NCT06669715 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Prehypertension (Elevated Blood Pressure) or Hypertension. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06669715 currently recruiting?

Yes, NCT06669715 is actively recruiting participants. Contact the research team at armin.paravlic@fsp.uni-lj.si for enrollment information.

Where is the NCT06669715 trial being conducted?

This trial is being conducted at Ljubljana, Slovenia.

Who is sponsoring the NCT06669715 clinical trial?

NCT06669715 is sponsored by University of Ljubljana. The principal investigator is Armin Paravlic, PhD at Faculty of Sport, University of Ljubljana. The trial plans to enroll 30 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology